ACET Articles, Aceto Corporation

No one has written and article on Aceto Corporation, stock symbol ACET. Be the first to contribute and write an article.

Stock Information

Aceto Corporation Company Name:

ACET Stock Symbol:

NASDAQ Market:

Aceto Corporation Website:

Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...

ACET - Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting

ADI-001 demonstrated 75% CR and ORR rate across all dose levels with favorable safety and tolerability profile in patients with relapsed/refractory high grade aggressive Non-Hodgkin’s Lymphoma (NHL) , a s of May 31, 2022 data-cut date 80% ORR and CR rate at dose...
ACET - Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)

As of the February 14, 2022 ASCO abstract data-cut date, ADI-001 demonstrated a 67% complete response rate with positive preliminary durability data and a favorable safety and tolerability profile Updated data from a May 31, 2022 data-cut date will be presented during oral presentat...
ACET - Adicet Bio to Present at Upcoming Investor Conferences

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor (CAR) T cell therapies for cancer, today announced that company management will participate in two upcoming investor confere...